Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

Détails

ID Serval
serval:BIB_6E08CDBE9844
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.
Périodique
European Journal of Internal Medicine
Auteur⸱e⸱s
Groh M., Pagnoux C., Baldini C., Bel E., Bottero P., Cottin V., Dalhoff K., Dunogué B., Gross W., Holle J., Humbert M., Jayne D., Jennette J.C., Lazor R., Mahr A., Merkel P.A., Mouthon L., Sinico R.A., Specks U., Vaglio A., Wechsler M.E., Cordier J.F., Guillevin L.
ISSN
1879-0828 (Electronic)
ISSN-L
0953-6205
Statut éditorial
Publié
Date de publication
2015
Peer-reviewed
Oui
Volume
26
Numéro
7
Pages
545-553
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
OBJECTIVE: To develop disease-specific recommendations for the diagnosis and management of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) (EGPA).
METHODS: The EGPA Consensus Task Force experts comprised 8 pulmonologists, 6 internists, 4 rheumatologists, 3 nephrologists, 1 pathologist and 1 allergist from 5 European countries and the USA. Using a modified Delphi process, a list of 40 questions was elaborated by 2 members and sent to all participants prior to the meeting. Concurrently, an extensive literature search was undertaken with publications assigned with a level of evidence according to accepted criteria. Drafts of the recommendations were circulated for review to all members until final consensus was reached.
RESULTS: Twenty-two recommendations concerning the diagnosis, initial evaluation, treatment and monitoring of EGPA patients were established. The relevant published information on EGPA, antineutrophil-cytoplasm antibody-associated vasculitides, hypereosinophilic syndromes and eosinophilic asthma supporting these recommendations was also reviewed.
DISCUSSION: These recommendations aim to give physicians tools for effective and individual management of EGPA patients, and to provide guidance for further targeted research.
Mots-clé
Advisory Committees, Churg-Strauss Syndrome/diagnosis, Churg-Strauss Syndrome/drug therapy, Consensus, Disease Management, Europe, Glucocorticoids/therapeutic use, Granulomatosis with Polyangiitis/diagnosis, Granulomatosis with Polyangiitis/drug therapy, Humans, Immunosuppressive Agents/therapeutic use, Rituximab/therapeutic use, United States
Pubmed
Web of science
Open Access
Oui
Création de la notice
03/01/2016 16:47
Dernière modification de la notice
20/08/2019 14:27
Données d'usage